In ovarian cancer, BRCA1-mut cancer genes such as AIF1, CD8A, and BST1 showed detrimental prognosis, while in BRCA2-mut ovarian cancer, SEC61A2 and IGFBP3 were associated with shorter survival (Figure 3A). This evidence concerns the gene IGFBP3 and ovarian carcinoma.